We manufacture and provide CLODRONIC ACID
CAS 10596-23-3
Purity is ≥ 98%
Cangrelor:
is a P2Y12 inhibitor FDA approved as of June 2015 as an antiplatelet drug for intravenous application. Some P2Y12 inhibitors are used
clinically as effective inhibitors of adenosine diphosphate-mediated platelet activation and aggregation.